Ignite Creation Date:
2024-05-06 @ 12:48 AM
Last Modification Date:
2024-10-26 @ 10:55 AM
Study NCT ID:
NCT01664000
Status:
COMPLETED
Last Update Posted:
2016-02-24
First Post:
2012-08-02
Brief Title:
A Safety Pharmacokinetic and Pharmacodynamic Study of Kevetrin in Patients With Advanced Solid Tumors
Sponsor:
Cellceutix Corporation
Organization:
Cellceutix Corporation
Organization Data
Organization:
Cellceutix Corporation
Class:
INDUSTRY
Study ID:
CTIX 12-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cellceutix Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Beth Israel Deaconess Medical Center | OTHER |
| Dana-Farber Cancer Institute | OTHER |